Alzheimer’s Disease: A Tiny Step Forward
The progression of Alzheimer’s disease was arrested in four patients who received an intravenous antibody treatment over three years, researchers reported at a conference in Vancouver, British Columbia.
The progression of Alzheimer’s disease was arrested in four patients who received an intravenous antibody treatment over three years, researchers reported at a conference in Vancouver, British Columbia.
Researchers noted that the results were inconclusive since they involved such a small group of patients. But with Alzheimer’s still mostly a mystery to medical science, any small step forward in treatment is good news.
— Posted by Alexander Reed Kelly
Your support matters…MedPage Today:
… The highlight finding, Relkin said, was that 3-year ADAS-Cog and CGIC scores in the four patients who received 0.4 g/kg every 2 weeks throughout the study were the same as at baseline.
Untreated Alzheimer’s disease patients in his clinic nearly always show measurable decline in 3 to 6 months, he said.
Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
In 'Knife,' his memoir on narrowly surviving a vicious attack, the acclaimed author interrogates a world where liberal principles have become old-fashioned.
Ear to the Ground
With summer on the way, advocates say access to cool air amidst stifling heat is a constitutional right.
Film
In “I Am Gitmo,” French director Philippe Diaz recreates the torture rooms inside the Guantanamo Bay Detention Center.
Editorial Cartoons
Editorial Cartoons
Editorial Cartoons
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.